LENSAR (NASDAQ:LNSR) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of LENSAR (NASDAQ:LNSR) from a sell rating to a hold rating in a report published on Saturday morning.

A number of other equities research analysts also recently commented on the stock. Weiss Ratings reiterated a “sell (d+)” rating on shares of LENSAR in a report on Friday, August 7th. BTIG Research boosted their price objective on shares of LENSAR from $7.00 to $9.00 and gave the company a “buy” rating in a research report on Thursday, August 13th. Finally, Lake Street Capital reissued a “buy” rating and set a $13.00 price objective on shares of LENSAR in a research note on Thursday. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $11.00.

LENSAR Stock Down 1.3%

LNSR opened at $8.09 on Friday. The firm has a market cap of $99.35 million, a P/E ratio of -24.52 and a beta of 0.89. LENSAR has a 52 week low of $4.95 and a 52 week high of $12.96. The business’s fifty day simple moving average is $5.94 and its 200 day simple moving average is $7.31.

LENSAR (NASDAQ:LNSR) last posted its quarterly earnings data on Thursday, August 13th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.26. LENSAR had a negative return on equity of 529.08% and a net margin of 57.57%.The firm had revenue of $16.50 million during the quarter, compared to analysts’ expectations of $14.65 million.

Hedge Funds Weigh In On LENSAR

A number of large investors have recently bought and sold shares of LNSR. Goldman Sachs Group Inc. acquired a new position in shares of LENSAR in the 1st quarter valued at $546,000. Acadian Asset Management LLC acquired a new stake in LENSAR during the 1st quarter worth approximately $257,000. Geode Capital Management LLC raised its holdings in LENSAR by 103.9% in the second quarter. Geode Capital Management LLC now owns 219,373 shares of the company’s stock valued at $2,890,000 after buying an additional 111,802 shares during the period. JPMorgan Chase & Co. raised its holdings in LENSAR by 584.3% in the second quarter. JPMorgan Chase & Co. now owns 4,674 shares of the company’s stock valued at $62,000 after buying an additional 3,991 shares during the period. Finally, New York State Common Retirement Fund acquired a new position in LENSAR during the second quarter valued at approximately $105,000. Hedge funds and other institutional investors own 40.15% of the company’s stock.

LENSAR Company Profile

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.